Trial intelligence / Profile preview

Metronidazole after ileocolic resection for Crohn's disease

NCT04682522Phase 4Completed

Sponsor
University of Louisville
Start
Mar 2021
Primary completion
Aug 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of metronidazole in Crohn's disease, sponsored by University of Louisville. Started Mar 2021; status: completed.

02

Drugs

metronidazole
03

Conditions

Crohn's disease

Beyond the preview

Go deeper on NCT04682522.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04682522.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call